WELL Health Announces Proposed TSXV Listing and Concurrent Financing for WELLSTAR, One of Canada’s Leading Healthcare Software and AI Platforms
WELL Health announced plans to spin out its subsidiary WELLSTAR via a TSXV listing through an amalgamation with 818, supported by a C$50 million concurrent brokered private placement priced at C$10.00 per share. WELLSTAR is a profitable, high-growth healthcare software platform expected to generate $95 million in revenue for 2026 with a 21% Adjusted EBITDA margin; WELL will retain a controlling 81.6% of voting rights post-listing.
Key figures
- Revenue
- 95000000
- Guidance
- 2026 revenue of approximately $95 million
- Offering Price
- 10
- Revenue cagr
- 20%
- Q1 2026 revenue
- 22000000
- Offering proceeds
- C$50 million
- 2026 ebitda margin
- 21%
- Q1 2026 yoy growth
- 26%
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.